<DOC>
	<DOCNO>NCT00484601</DOCNO>
	<brief_summary>This research test effectiveness toxicity Ifosfamide Doxorubicin . It also aim explore relationship EBV DNA clinical response patient advance naso-pharyngeal cancer previously treat chemotherapy .</brief_summary>
	<brief_title>Ifosfamide Doxorubicin Patients With Refractory Nasopharyngeal Carcinoma</brief_title>
	<detailed_description>Nasopharyngeal Cancer ( NPC ) one common cancer Southeast Asia . In region NPC associate Epstein Barr Virus ( EBV ) chronic infection EBV DNA identifiable almost NPC tumor patient 's serum time diagnosis . Chinese , especially cantonese high incidence . Only 30 % patient present early disease good treatment outcome ( 80 % cure stage I disease 70 % stage II radiation ) . This research test effectiveness toxicity Ifosfamide Doxorubicin . It also aim explore relationship EBV DNA clinical response patient advance naso-pharyngeal cancer previously treat chemotherapy . Investigators believe EBV infection necessary cause NPC EBV DNA level blood may directly relate total size tumor . Because NPC patient situation poor outlook , design study evaluate combination Ifosfamide doxorubicin treatment . While combination medicine use many form cancer , test patient NPC .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Isophosphamide mustard</mesh_term>
	<mesh_term>Ifosfamide</mesh_term>
	<criteria>Histological diagnosis NPC Age &gt; 18 year old Measurable metastatic recurrent disease ( ) Received one prior chemotherapy regimen metastatic recurrent NPC relapse become refractory entry . ECOG PS 0 , 1 2 WBC &gt; 3,500/uL ANC &gt; 1,500/uL Platelet &gt; 100,000/uL Creatinine within normal limit SGOT &lt; 3 X UNL Bilirubin &lt; 2.0 mg/dL Ejection fraction &gt; 45 % history myocardial infarction congestive heart failure last 6 month . No history cardiac ventricular arrythmia ventricle tachycardia , uncontrolled atrial fibrillation supraventricular tachycardia hemodynamic compromising status . Random blood glucose level &lt; 250 mg Signed informed consent Received one prior chemotherapy metastatic recurrent disease Ejection fraction &lt; 45 % WBC &lt; 3,500/UL ANC &lt; 1,500/UL P/t &lt; 100,000/UL SCOT &gt; 3 x UNL Bilirubin &gt; 2.0 mg/dL Creatinine &gt; UNL ECOG PS &gt; 3 Hx myocardial infarction within last 6 month Random blood glucose level less equal 250 mg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2008</verification_date>
</DOC>